• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Social Capital Suvretta Holdings Corp. IV filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits

    9/8/22 7:31:02 AM ET
    $DNAD
    Blank Checks
    Finance
    Get the next $DNAD alert in real time by email
    8-K
    NASDAQ false 0001850272 0001850272 2022-09-02 2022-09-02

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    Current Report

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 2, 2022

     

     

    SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV

    (Exact name of registrant as specified in its charter)

     

     

    Commission file number: 001-40561

     

    Cayman Islands   98-1586546
    (State of incorporation)  

    (I.R.S. Employer

    Identification No.)

     

    2850 W. Horizon Ridge Parkway, Suite 200

    Henderson, NV

      89052
    (Address of principal executive offices)   (Zip Code)

    (650) 521-9007

    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

      

    Trading
    Symbol(s)

      

    Name of each exchange
    on which registered

    Class A ordinary shares, $0.0001 par value per share    DNAD    Nasdaq Capital Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company  ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

     

     

     


    Item 3.01

    Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    On September 2, 2022, Social Capital Suvretta Holdings Corp. IV (the “Company”) was notified by the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the audit committee composition requirements set forth in Nasdaq Listing Rule 5605 (the “Rule”), due to the previously disclosed departure of a member of the Company’s board of directors (the “Board”) and audit committee. The Staff notified the Company that it will provide the Company a cure period to regain compliance with the Rule by the earlier of the Company’s next annual shareholders’ meeting or August 4, 2023 (or, if the Company’s next annual shareholders’ meeting is held before January 31, 2023, then no later than January 31, 2023).

    As a result of the appointment of William J. Newell to the Board and the audit committee of the Board, as described in Item 5.02 of this Current Report on Form 8-K, the Company has regained compliance with the audit committee composition requirements set forth in the Rule.

     

    Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On September 7, 2022, William J. Newell was appointed to the Board. Effective September 7, 2022, Mr. Newell was also appointed to the audit committee, the compensation committee and the nominating and corporate governance committee of the Board. The Board has determined that Mr. Newell is an independent director under applicable Securities and Exchange Commission and Nasdaq Capital Market rules.

    In connection with the appointment of Mr. Newell, the Company entered into the following agreements:

     

      •  

    A Letter Agreement, dated September 7, 2022 (the “Letter Agreement”), between the Company and William J. Newell, pursuant to which Mr. Newell has agreed to: vote any ordinary shares of the Company held by him in favor of the Company’s initial business combination; facilitate the liquidation and winding up of the Company if an initial business combination is not consummated within the time period required by the Company’s amended and restated memorandum and articles of association; and certain transfer restrictions with respect to the Company’s securities.

     

      •  

    An Indemnity Agreement, dated September 7, 2022 (the “Indemnity Agreement”), between the Company and William J. Newell, providing Mr. Newell contractual indemnification in addition to the indemnification provided for in the Company’s amended and restated memorandum and articles of association.

     

      •  

    A Director Restricted Stock Unit Award Agreement, dated September 7, 2022 (the “Restricted Stock Unit Award Agreement”), between the Company and William J. Newell, providing for the grant of 30,000 restricted stock units (“RSUs”) to Mr. Newell, which grant is contingent on (i) the Company’s consummation of an initial business combination and (ii) a shareholder approved equity plan. The RSUs will vest upon the consummation of such initial business combination (the “Vesting Date”) and represent 30,000 Class A ordinary shares (or, following a domestication by the Company as a Delaware corporation, shares of common stock) of the Company that will settle on a date determined in the sole discretion of the Company that shall occur between the Vesting Date and March 15 of the year following the year in which vesting occurs.

    The foregoing descriptions of the Letter Agreement, the Indemnity Agreement and the Restricted Stock Unit Award Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement, the Indemnity Agreement and the Restricted Stock Unit Award Agreement, copies of which are attached hereto as Exhibits 10.1, 10.2 and 10.3, respectively, and are incorporated herein by reference.

    The Company will reimburse Mr. Newell for reasonable out-of-pocket expenses incurred in connection with fulfilling his role as a director. Other than the foregoing, Mr. Newell is not party to any arrangement or understanding with any person pursuant to which he was appointed as a director, nor is he party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.


    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit
    No.

      

    Description

    10.1    Letter Agreement, dated September 7, 2022, between the Company and William J. Newell.
    10.2    Indemnity Agreement, dated September 7, 2022, between the Company and William J. Newell.
    10.3    Director Restricted Stock Unit Award Agreement, dated September 7, 2022, between the Company and William J. Newell.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV
    By:  

    /s/ James Ryans

      James Ryans
      Chief Financial Officer

    Dated: September 8, 2022

    Get the next $DNAD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DNAD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DNAD
    SEC Filings

    View All

    SEC Form 15-12G filed by Social Capital Suvretta Holdings Corp. IV

    15-12G - Social Capital Suvretta Holdings Corp. IV (0001850272) (Filer)

    7/11/23 1:07:56 PM ET
    $DNAD
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Social Capital Suvretta Holdings Corp. IV

    25-NSE - Social Capital Suvretta Holdings Corp. IV (0001850272) (Subject)

    6/30/23 5:00:38 PM ET
    $DNAD
    Blank Checks
    Finance

    Social Capital Suvretta Holdings Corp. IV filed SEC Form 8-K: Other Events

    8-K - Social Capital Suvretta Holdings Corp. IV (0001850272) (Filer)

    5/26/23 4:46:12 PM ET
    $DNAD
    Blank Checks
    Finance

    $DNAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Newell William J

    3 - Social Capital Suvretta Holdings Corp. IV (0001850272) (Issuer)

    9/9/22 4:12:09 PM ET
    $DNAD
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Amin Biren

    3 - Social Capital Suvretta Holdings Corp. IV (0001850272) (Issuer)

    7/6/22 4:33:18 PM ET
    $DNAD
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Solomon Steven Marc

    3 - Social Capital Suvretta Holdings Corp. IV (0001850272) (Issuer)

    9/24/21 4:57:45 PM ET
    $DNAD
    Blank Checks
    Finance

    $DNAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Social Capital Suvretta Holdings Corp. IV (Amendment)

    SC 13G/A - Social Capital Suvretta Holdings Corp. IV (0001850272) (Subject)

    2/7/24 2:14:00 PM ET
    $DNAD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Social Capital Suvretta Holdings Corp. IV (Amendment)

    SC 13G/A - Social Capital Suvretta Holdings Corp. IV (0001850272) (Subject)

    2/14/23 12:19:04 PM ET
    $DNAD
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Social Capital Suvretta Holdings Corp. IV (Amendment)

    SC 13G/A - Social Capital Suvretta Holdings Corp. IV (0001850272) (Subject)

    2/14/23 6:48:43 AM ET
    $DNAD
    Blank Checks
    Finance